Multiple Bactericidal Mechanisms of the Zinc Ionophore PBT2

ABSTRACT Globally, more antimicrobials are used in food-producing animals than in humans, and the extensive use of medically important human antimicrobials poses a significant public health threat in the face of rising antimicrobial resistance (AMR). The development of novel ionophores, a class of a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nichaela Harbison-Price, Scott A. Ferguson, Adam Heikal, George Taiaroa, Kiel Hards, Yoshio Nakatani, David Rennison, Margaret A. Brimble, Ibrahim M. El-Deeb, Lisa Bohlmann, Christopher A. McDevitt, Mark von Itzstein, Mark J. Walker, Gregory M. Cook
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://doaj.org/article/7ba6568165cb4f2489d265bf769ffb42
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7ba6568165cb4f2489d265bf769ffb42
record_format dspace
spelling oai:doaj.org-article:7ba6568165cb4f2489d265bf769ffb422021-11-15T15:29:16ZMultiple Bactericidal Mechanisms of the Zinc Ionophore PBT210.1128/mSphere.00157-202379-5042https://doaj.org/article/7ba6568165cb4f2489d265bf769ffb422020-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00157-20https://doaj.org/toc/2379-5042ABSTRACT Globally, more antimicrobials are used in food-producing animals than in humans, and the extensive use of medically important human antimicrobials poses a significant public health threat in the face of rising antimicrobial resistance (AMR). The development of novel ionophores, a class of antimicrobials used exclusively in animals, holds promise as a strategy to replace or reduce essential human antimicrobials in veterinary practice. PBT2 is a zinc ionophore with recently demonstrated antibacterial activity against several Gram-positive pathogens, although the underlying mechanism of action is unknown. Here, we investigated the bactericidal mechanism of PBT2 in the bovine mastitis-causing pathogen, Streptococcus uberis. In this work, we show that PBT2 functions as a Zn2+/H+ ionophore, exchanging extracellular zinc for intracellular protons in an electroneutral process that leads to cellular zinc accumulation. Zinc accumulation occurs concomitantly with manganese depletion and the production of reactive oxygen species (ROS). PBT2 inhibits the activity of the manganese-dependent superoxide dismutase, SodA, thereby impairing oxidative stress protection. We propose that PBT2-mediated intracellular zinc toxicity in S. uberis leads to lethality through multiple bactericidal mechanisms: the production of toxic ROS and the impairment of manganese-dependent antioxidant functions. Collectively, these data show that PBT2 represents a new class of antibacterial ionophores capable of targeting bacterial metal ion homeostasis and cellular redox balance. We propose that this novel and multitarget mechanism of PBT2 makes the development of cross-resistance to medically important antimicrobials unlikely. IMPORTANCE More antimicrobials are used in food-producing animals than in humans, and the extensive use of medically important human antimicrobials poses a significant public health threat in the face of rising antimicrobial resistance. Therefore, the elimination of antimicrobial crossover between human and veterinary medicine is of great interest. Unfortunately, the development of new antimicrobials is an expensive high-risk process fraught with difficulties. The repurposing of chemical agents provides a solution to this problem, and while many have not been originally developed as antimicrobials, they have been proven safe in clinical trials. PBT2, a zinc ionophore, is an experimental therapeutic that met safety criteria but failed efficacy checkpoints against both Alzheimer’s and Huntington’s diseases. It was recently found that PBT2 possessed potent antimicrobial activity, although the mechanism of bacterial cell death is unresolved. In this body of work, we show that PBT2 has multiple mechanisms of antimicrobial action, making the development of PBT2 resistance unlikely.Nichaela Harbison-PriceScott A. FergusonAdam HeikalGeorge TaiaroaKiel HardsYoshio NakataniDavid RennisonMargaret A. BrimbleIbrahim M. El-DeebLisa BohlmannChristopher A. McDevittMark von ItzsteinMark J. WalkerGregory M. CookAmerican Society for Microbiologyarticleantimicrobial resistancePBT2zincmanganeseionophoremetal ion homeostasisMicrobiologyQR1-502ENmSphere, Vol 5, Iss 2 (2020)
institution DOAJ
collection DOAJ
language EN
topic antimicrobial resistance
PBT2
zinc
manganese
ionophore
metal ion homeostasis
Microbiology
QR1-502
spellingShingle antimicrobial resistance
PBT2
zinc
manganese
ionophore
metal ion homeostasis
Microbiology
QR1-502
Nichaela Harbison-Price
Scott A. Ferguson
Adam Heikal
George Taiaroa
Kiel Hards
Yoshio Nakatani
David Rennison
Margaret A. Brimble
Ibrahim M. El-Deeb
Lisa Bohlmann
Christopher A. McDevitt
Mark von Itzstein
Mark J. Walker
Gregory M. Cook
Multiple Bactericidal Mechanisms of the Zinc Ionophore PBT2
description ABSTRACT Globally, more antimicrobials are used in food-producing animals than in humans, and the extensive use of medically important human antimicrobials poses a significant public health threat in the face of rising antimicrobial resistance (AMR). The development of novel ionophores, a class of antimicrobials used exclusively in animals, holds promise as a strategy to replace or reduce essential human antimicrobials in veterinary practice. PBT2 is a zinc ionophore with recently demonstrated antibacterial activity against several Gram-positive pathogens, although the underlying mechanism of action is unknown. Here, we investigated the bactericidal mechanism of PBT2 in the bovine mastitis-causing pathogen, Streptococcus uberis. In this work, we show that PBT2 functions as a Zn2+/H+ ionophore, exchanging extracellular zinc for intracellular protons in an electroneutral process that leads to cellular zinc accumulation. Zinc accumulation occurs concomitantly with manganese depletion and the production of reactive oxygen species (ROS). PBT2 inhibits the activity of the manganese-dependent superoxide dismutase, SodA, thereby impairing oxidative stress protection. We propose that PBT2-mediated intracellular zinc toxicity in S. uberis leads to lethality through multiple bactericidal mechanisms: the production of toxic ROS and the impairment of manganese-dependent antioxidant functions. Collectively, these data show that PBT2 represents a new class of antibacterial ionophores capable of targeting bacterial metal ion homeostasis and cellular redox balance. We propose that this novel and multitarget mechanism of PBT2 makes the development of cross-resistance to medically important antimicrobials unlikely. IMPORTANCE More antimicrobials are used in food-producing animals than in humans, and the extensive use of medically important human antimicrobials poses a significant public health threat in the face of rising antimicrobial resistance. Therefore, the elimination of antimicrobial crossover between human and veterinary medicine is of great interest. Unfortunately, the development of new antimicrobials is an expensive high-risk process fraught with difficulties. The repurposing of chemical agents provides a solution to this problem, and while many have not been originally developed as antimicrobials, they have been proven safe in clinical trials. PBT2, a zinc ionophore, is an experimental therapeutic that met safety criteria but failed efficacy checkpoints against both Alzheimer’s and Huntington’s diseases. It was recently found that PBT2 possessed potent antimicrobial activity, although the mechanism of bacterial cell death is unresolved. In this body of work, we show that PBT2 has multiple mechanisms of antimicrobial action, making the development of PBT2 resistance unlikely.
format article
author Nichaela Harbison-Price
Scott A. Ferguson
Adam Heikal
George Taiaroa
Kiel Hards
Yoshio Nakatani
David Rennison
Margaret A. Brimble
Ibrahim M. El-Deeb
Lisa Bohlmann
Christopher A. McDevitt
Mark von Itzstein
Mark J. Walker
Gregory M. Cook
author_facet Nichaela Harbison-Price
Scott A. Ferguson
Adam Heikal
George Taiaroa
Kiel Hards
Yoshio Nakatani
David Rennison
Margaret A. Brimble
Ibrahim M. El-Deeb
Lisa Bohlmann
Christopher A. McDevitt
Mark von Itzstein
Mark J. Walker
Gregory M. Cook
author_sort Nichaela Harbison-Price
title Multiple Bactericidal Mechanisms of the Zinc Ionophore PBT2
title_short Multiple Bactericidal Mechanisms of the Zinc Ionophore PBT2
title_full Multiple Bactericidal Mechanisms of the Zinc Ionophore PBT2
title_fullStr Multiple Bactericidal Mechanisms of the Zinc Ionophore PBT2
title_full_unstemmed Multiple Bactericidal Mechanisms of the Zinc Ionophore PBT2
title_sort multiple bactericidal mechanisms of the zinc ionophore pbt2
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/7ba6568165cb4f2489d265bf769ffb42
work_keys_str_mv AT nichaelaharbisonprice multiplebactericidalmechanismsofthezincionophorepbt2
AT scottaferguson multiplebactericidalmechanismsofthezincionophorepbt2
AT adamheikal multiplebactericidalmechanismsofthezincionophorepbt2
AT georgetaiaroa multiplebactericidalmechanismsofthezincionophorepbt2
AT kielhards multiplebactericidalmechanismsofthezincionophorepbt2
AT yoshionakatani multiplebactericidalmechanismsofthezincionophorepbt2
AT davidrennison multiplebactericidalmechanismsofthezincionophorepbt2
AT margaretabrimble multiplebactericidalmechanismsofthezincionophorepbt2
AT ibrahimmeldeeb multiplebactericidalmechanismsofthezincionophorepbt2
AT lisabohlmann multiplebactericidalmechanismsofthezincionophorepbt2
AT christopheramcdevitt multiplebactericidalmechanismsofthezincionophorepbt2
AT markvonitzstein multiplebactericidalmechanismsofthezincionophorepbt2
AT markjwalker multiplebactericidalmechanismsofthezincionophorepbt2
AT gregorymcook multiplebactericidalmechanismsofthezincionophorepbt2
_version_ 1718427893561819136